Feedback / Questions
EL-22 - PMGC Holdings
https://www.globenewswire.com/news-release/2025/05/22/3086576/0/en/NorthStrive-Biosciences-Announces-Completion-of-Phase-I-Strategic-Review-for-EL-22-Targeting-Muscle-Loss-Associated-with-GLP-1-Weight-Loss-Drugs-and-Age-Related-Sarcopenia.html
May 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next